A new approach for pharmacokinetic studies of natural products: measurement of isoliquiritigenin levels in mice plasma, urine and feces using modified automated dosing/blood sampling system

Effects of cysteine on the pharmacokinetics of tamoxifen in rats with protein-calorie malnutrition

Saturable sinusoidal uptake is rate-determining process in hepatic elimination of docetaxel in rats

Reduced clearance of e-acetamidocaproic acid in rats with acute renal failure induced by uranyl nitrate

Pharmacokinetic interaction between metoprolol and SP-8203 in rats: competitive inhibition for the metabolism of metoprolol by SP-8203 via hepatic CYP2D subfamily

Effects of cysteine on the pharmacokinetics of docetaxel in rats with protein-calorie malnutrition

Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes

ε-Acetamidocaproic acid pharmacokinetics in rats with gastric ulcer or small bowel inflammation

Pharmacokinetic interaction between epsilon-acetamidocaproic acid (AACA) and cimetidine in indomethacin-induced acute gastric ulcer and control rats: inhibition of active renal secretion of AACA by cimetidine

Simultaneous LC-MS-MS determination of HM30181A, [2-(2-{4-[2-(6,7- dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl)-4, 5-dimethoxyphenyl]amide, as a new P-glycoprotein inhibitor and its two metabolites, M1 and M2, in human plasma: Application to a pharmacokinetic study